文献速递类风湿关节炎

类风湿关节炎与骨关节炎生活方式干预的长期有效性:「植物为关节」随机临床试验的1年随访

Long-term effectiveness of a lifestyle intervention for rheumatoid arthritis and osteoarthritis: 1-year follow-up of the 'Plants for Joints' randomised clinical trial.
PubMed 文献 · RMD Open · 2024-02-27

在两项随机对照试验完成后,对照组转为「植物为关节」(PFJ)多学科生活方式干预,随后进行1年观察性延长期随访;结果显示,RA组DAS28平均下降0.9分(p<0.001),MSOA组WOMAC平均下降7.8分(p<0.001),代谢指标改善及用药净减少得以维持。

要点

  • RA组干预完成后1年,DAS28较基线平均下降0.9分(p<0.001),疾病活动改善持续存在。
  • MSOA组WOMAC平均下降7.8分(p<0.001),较干预结束时有所回升但仍远低于起始值。
  • C反应蛋白、腰围等代谢指标改善及用药净减少在两组中均得以持续,干预依从性基本维持。

核心结论

  • PFJ生活方式干预完成1年后,RA组和MSOA组的疾病活动与代谢结局改善基本得以维持,且与持续依从性相关,同时用药净减少。

研究设计与样本

  • 本研究为两项16周随机对照试验完成后的1年观察性延长期随访,原对照组在试验结束后转为PFJ干预,所有参与者进入延长期随访。
  • RA试验纳入77例类风湿关节炎患者,MSOA试验纳入64例代谢综合征相关髋或膝骨关节炎患者,采用意向性治疗线性混合模型分析组内变化。

主要发现

  • 77例RA参与者中65例(84%)完成延长期研究,64例MSOA参与者中49例(77%)完成延长期研究。
  • RA组干预完成后1年DAS28平均下降0.9分(p<0.001);MSOA组WOMAC平均下降7.8分(p<0.001)。
  • RA组和MSOA组的C反应蛋白、腰围改善得以持续;RA组低密度脂蛋白胆固醇改善持续;MSOA组体重、糖化血红蛋白、血压改善持续。
  • 参与者用药净减少,干预依从性基本持续。

关键数值与推荐

  • RA组主要结局为28关节疾病活动度评分(DAS28),干预完成后1年平均下降0.9分(p<0.001)。
  • MSOA组主要结局为西安大略和麦克马斯特大学骨关节炎指数(WOMAC),平均下降7.8分(p<0.001)。

临床怎么用

  • 原文未据此给出临床推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: In two randomised controlled trials, the Plants for Joints (PFJ) multidisciplinary lifestyle intervention reduced signs and symptoms of rheumatoid arthritis (RA), or metabolic syndrome-associated hip or knee osteoarthritis (MSOA) compared with usual care. The current study investigated long-term outcomes. METHODS: After completion of two 16-week trials in people with (1) RA or (2) MSOA, control groups switched to the active PFJ intervention. At the end of the intervention, all participants were followed up in a 1-year observational extension study. Primary outcomes were 28-joint Disease Activity Score (DAS28) (RA) and Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) (MSOA). Secondary outcomes included body composition, metabolic outcomes, medication changes and intervention adherence. An intention-to-treat analysis with a linear mixed model was used to analyse within-group changes. RESULTS: 65 (84%) of 77 RA participants and 49 (77%) of 64 MSOA participants completed the extension study. The effects of the PFJ intervention were replicated in the original control groups and sustained within the RA group a year after intervention completion (mean DAS28 -0.9 points; p<0.001), while in the MSOA group mean WOMAC increased towards but remained well under the starting value (-7.8 points, p<0.001). Improvements in C-reactive protein, waist circumference (RA and MSOA); low-density lipoprotein cholesterol (RA); and weight, haemoglobin A1c, blood pressure (MSOA) were also sustained. Participants had a net decrease of medication, and intervention adherence was largely sustained. CONCLUSIONS: A year after the PFJ lifestyle intervention, improvements of disease activity and metabolic outcomes within RA and MSOA groups were largely sustained and related to sustained adherence, with a net decrease of medication. TRIAL REGISTRATION NUMBERS: NL7800, NL7801.

来源:RMD Open,查看原文。版权归原作者所有。

引用

  1. Wagenaar CA, Walrabenstein W, van der Leeden M, et al. Long-term effectiveness of a lifestyle intervention for rheumatoid arthritis and osteoarthritis: 1-year follow-up of the 'Plants for Joints' randomised clinical trial. RMD Open. 2024. PMID: 38413171. doi:10.1136/rmdopen-2023-004025

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。